p53 Mutations in Hodgkin's disease

Laboratory Investigation

Volumn 75, Issue 4, 1996, Pages 519-527

  Chen, Wen Gang ^a   Chen, Yuan Yuan ^a   Kamel, Onsi W ^b   Koo, Chae H ^c   Weiss, Lawrence M ^a,d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

^c KAISER FOUNDATION HOSPITAL   (United States)

^d Division of Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; DNA STRUCTURE; EPSTEIN BARR VIRUS; GENE MUTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REED STERNBERG CELL;

BASE SEQUENCE; BLOTTING, SOUTHERN; DNA, VIRAL; EXONS; GENE EXPRESSION; GENES, P53; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; MUTATION; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; REED-STERNBERG CELLS;

EID: 0029862456     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, and Sidransky D (1995). Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 332:429-435.
2. Cesarman E, Inghirami G, Chadburn A, and Knowles DM (1993). High levels of p53 protein expression do not correlate with p53 gene mutation in anaplastic large cell lymphoma. Am J Pathol 143:845-856.
3. Cesarman E, Liu YF, and Knowles DM (1994). The MDM2 oncogene is rarely amplified in human lymphoid tumors and does not correlate with p53 gene expression. Int J Cancer 56:457-458.
4. Chang KL, Chen Y-Y, Shibata D, and Weiss LM (1992). In situ hybridization methodology for the detection of EBV EBER-1 RNA in paraffin-embedded tissues, as applied to normal and neoplastic tissues. Diagn Mol Pathol 1:246-255.
5. Chilosi M, Doglioni C, Menestrina F, Montagna L, Rigo A, Lestani M, Barbareschi M, Scarpa A, Mariuzzi GM, and Pizzolo G (1994). Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood 84:4295-4300.
6. Cho Y, Gorina S, Jeffrey P, and Pavletich N (1994). Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigneic mutations. Science 265:346-355.
7. Czader M, Porwit A, Ost A, and Auer G (1994). DNA content and expression of PCNA and p53 in Hodgkin's disease and Hodgkin's-like B-cell lympoma. APMIS 102:865-873.
8. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks J, Rickinson AB, and Young LS (1993). Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339-349.
9. Doglioni C, Pelosio P, Mombello A, Scarpa A, and Chilosi M (1991). Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's diesase and CD30+ anaplastic lymphomas. Hematol Pathol 5:67-73.
10. Doussis IA, Pezzella F, Lane DP, Gatter KC, and Mason DY (1993). An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am J Clin Pathol 99:663-667.
11. Gown AM, deWever N, and Battifora H (1993). Microwave-based antigenic unmasking: A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256-266.
12. Gupta RK, Norton AJ, Lister TA, and Bodmer JG (1993a). p53 protein expression in Reed-Sternberg cells of Hodgkin's disease. Leukemia 7:S31-S33.
13. Gupta RK, Norton AJ, Thompson IW, Lister TA, and Bodmer JG (1992). p53 expression in Reed-Sternberg cells of Hodgkin's disease. Br J Cancer 66:649-652.
14. Gupta RK, Patel K, Bodmer WF, and Bodmer JG (1993b). Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease. Proc Natl Acad Sci USA 90:2817-2821.
15. Halevy O, Hall A, and Oren M (1989). Stabilization of the p53 transformation-related protein in mouse fibrosarcoma cell lines: Effects of protein sequence and intracellular environment. Mol Cell Biol 9:3385-3392.
16. Inghirami G, Macri L, Rosati S, Zhu BY, Yee H, and Knowles D (1994). The Reed-Sternberg cells of Hodgkin disease are clonal. Proc Natl Acad Sci USA 91:9842-9846.
17. Lauritzen AF, Hou-Jensen K, and Ralfkiaer E (1993). p53 protein expression in Hodgkin's disease. APMIS 101:689-694.
18. Lehtinen T, Aine R, Kellokumpu-Lehtinen P, Hakala T, and Lehtinen M (1993). Evaluation of plasma levels of thymidine kinase and mutated p53 in 81 patients with newly diagnosed malignant lymphoma. Acta Oncol 32:779-781.
19. Levine AJ, Momand J, and Finlay CA (1991). The p53 tumour suppressor gene. Nature 351:453-456.
20. Lukes RJ, Craver LF, Hall TC, Rappaport H, and Rubin T (1966). Report of the nomenclature committee. Cancer Res 26:1311.
21. Martinez JC, Mateo M, Sanchez-Beato M, Villuendas R, Orradre JL, Algara P, Sanchez-Verde L, Garcia P, Lopez C, Martinez P, and Piris MA (1995). MDM2 expression in lymphoid cells and reactive and neoplastic lymphoid tissue: Comparative study with p53 expression. J Pathol 177:27-34.
22. Matsushima AY, Cesarman E, Chadburn A, and Knowles DM (1994). Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations. Am J Pathol 144:573-584.
23. Momand J, Zambetti GP, Olson DC, George D, and Levine A (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
24. Niedobitek G, Rowlands DC, Young LS, Herbst H, Williams A, Hall P, Padfield J, Rooney N, and Jones EL (1993). Overexpression of p53 in Hodgkin's disease: Lack of correlation with Epstein-Barr virus infection. J Pathol 169:207-212.
25. Said JW, Barrera R, Shintaku IP, Nakamura H, and Koeffler HP (1992). Immunohistochemical analysis of p53 expression in malignant lymphomas. Am J Pathol 141:1343-1348.
26. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promoted the degradation of p53. Cell 63:1129-1136.
27. Sidransky D, Von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, and Vogelstein B (1991). Identification of p53 gene mutations in bladder cancers and urine samples. Science 252:706-709.
28. Soini Y, Paakko P, Alavaikko M, and Vahakangas K (1992). p53 expression in lymphatic malignancies. J Clin Pathol 45:1011-1014.
29. Szekely L, Pokrovskaja K, Jiang W, Selivanova G, Lowbeer M, Ringertz N, Winman K, and Klein G (1995). Resting B-cells, EBV infected B-blasts and established lymphoblatoid cell lines differ in their Rb, p53 and EBNA-5 expression patterns. Oncogene 10:1869-1874.
30. Szekely L, Selivanova G, Magnusson K, Klein G, and Wiman K (1993). EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA 90:5455-5459.
31. Trumper LH, Brady G, Bagg A, Gray D, Loke S, Griesser H, Wagman R, Braziel R, Gascoyne RD, Vicini S, Iscove N, Cossman J, and Mak T (1993). Single-cell analysis of Hodgkin's and Reed-Sternberg cells: Molecular heterogeneity of gene expression and p53 mutations. Blood 81:3097-3115.
32. Trumper L, Daus H, Roth J, Loftin U, Gause A, and Pfreundschuh M (1995). Single cell PCR at the DNA and RNA level: A novel approach to the study of Hodgkin's disease. In: Jarrett RF, editor. Etiology of Hodgkin's disease, vol 280. New York: Plenum Press, 143-159.
33. Villuendas R, Piris MA, Algara P, Sanches-Beato M, Sanchez-Verde L, Martinez JC, Orradre JL, Garcia P, Lopez C, and Martinez P (1993). The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 82:3151-3156.
34. Vogelstein B and Kinzler KW (1994). X-rays strike p53 again. Nature 370:174-175.
35. Weiss LM, Chen Y-Y, Liu X-F, and Shibata D (1991). Epstein-Barr virus and Hodgkin's disease: A correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 139:1259-1265.
36. Xerri L, Bouabdallah R, Camerlo J, and Hassoun J (1994). Expression of the p53 gene in Hodgkin's disease: Dissociation between immunohistochemistry and clinicopathological data. Hum Pathol 25:449-454.
37. Xerri L, Parc P, Bouabdallah R, Camerlo J, and Hassoun J (1995). PCR-mismatch analysis of p53 gene mutation in Hodgkin's disease. J Pathol 175:189-194.